| | | September 15, 2023 Hey traders! It's Michael here with the Stock Dork Cheat Sheet: Premarket Report, your go-to guide for the day's biggest trading news and hottest premarket stocks! Happy Friday! It's September 15th. I hope you have a great weekend. Now, let's get ready to trade! |
| Stocks rallied on Thursday following the successful debut of the year's biggest IPO, Arm Holdings [ARM]. The small-cap Russell 2K led with a 1.4% rally, while the Dow gained 0.9%. The Nasdaq and S&P 500 tied with a 0.8% gain. Futures are up in early trading. S&P 500 contracts are showing a 0.1% gain ahead of the opening bell. The AI Singularity Clock Is Ticking⏰ The dot-com crash… the housing bubble… the COVID crash… but we've still never seen anything like what's coming for artificial intelligence in as little as three months. It's called the Singularity – and it refers to the exact millisecond when AI breaks free from its shackles to grow BILLIONS of times more powerful than humans. Click here to ensure you'll be on the right side of this historic event. 🔥 Arm Completes IPO with Flying ColorsU.K. chip designer Arm Holdings [ARM] completed its IPO on Thursday, and it closed the session with a 24.6% gain. Plus, it's up another 4.0% in today's premarket. Arm's successful debut sent a bullish signal to the IPO market. The Wall Street Journal reported that Instacart is already set to raise its IPO price in light of Arm's breakout debut. We could see more noteworthy IPOs occur before the end of the year, thanks to Arm's success. |
| Iovance Biotherapeutics [IOVA] - Last Close: $4.64 Iovance Bio is up after a clinical update. This morning, the tiny biotech said the FDA needs more time to complete its priority review of the company's lifileucel therapy due to resource constraints. FDA extended its target action date to Feb. 2024 and said it would work closely with Iovance to accelerate the remaining review in hopes of an earlier timetable. Iovance said regulators also reiterated that there are no major review issues and no plans to hold any advisory committee meetings. IOVA is up 17.7% on the news. My Take: Sounds like IOVA's lifileucel therapy is a shoo-in for FDA approval. This stock has gotten killed lately, but this could be a set-up for a rally down the road. 1847 Holdings [EFSH] - Last Close: $1.08 An update to a credit agreement is boosting shares of 1847 Holdings. Thursday evening, the retail conglomerate published a Form 8-K announcing the closing of a new revolving term loan facility. The company and its ICU Eyewear's loan facility was acquired by AB Lending on Sept. 11th, and the new lender immediately boosted 1847's credit limit. 1847 Holdings has now secured a revolving loan of $15 million, three-times its previous loan limit of $5 million. EFSH is up 9.3% in light of the news. My Take: REFSH was up by more earlier in the premarket session, but it looks like this rally is losing steam. Nikola [NKLA] - Last Close: $1.15 Nikola is riding a wave of positive sentiment after a big announcement. Earlier today, the zero-emission truckmaker announced the expansion of its dealer sales and services network into Canada via a partnership with ITD Industries. The partnership will expand the public's access to Nikola Class 8 truck sales and service coverage across Canada. ITD will promote Nikola's zero-emission trucks through its national sales channels, and it will hold an industry event this Fall to discuss the new partnership. NKLA is trading actively with a 14.7% gain. My Take: NKLA might be back. After a rocky debut a couple of years ago, the negative sentiment surrounding the company seems to be dissipating. This could be a promising swing trade set up. Novonix [NVX] - Last Close: $1.86 A recent business update is lifting shares of Novonix. Late Thursday, the battery metals supplier said a synthetic graphite production campaign using Gen 3 furnaces at its Riverside, TN plant met all specifications. The company said the graphite produced met all physical and electrochemical specifications, and it will continue with production to gather more data. In light of the advancement, the company doubled the annual production target for its TN facility from 10,000 tons to 20,000 tons. It also said it expects an ongoing refurbishment of the plant to conclude by Q1, 2024. NVX is up 18.8% on the news. My Take: NVX is pretty beaten down, but it looks like its business is on the right track. This stock could be a dark-horse play on the battery metals market, which could explode as EVs become more popular. GainersMSP Recovery [LIFW] >> +102.6%AgriFORCE Growing [AGRI] >> +56.1%Connex Sports Tech. [CNXA] >> +35.0%Golden Heaven [GDHG] >> +19.2%DeclinersVolcon [VLCN] >> (30.0%) Axcella Health (AXLA) >> (24.8%)PTC Therapeutics [PTCT] >> (27.7%)Avalo Therapeutics [AVTX] >> (19.2%) Lightinthebox Holding Co., LTD. [LITB] ... AM U.S. import prices [Aug] ... 8:30aEmpire State manufacturing survey [Sep] ... 8:30aIndustrial production [Aug] ... 9:15aCapacity utilization [Aug] ... 9:15aConsumer sentiment (prelim) [Aug] ... 10:00a |
| Thanks for reading! Don't forget, I'm always eager to hear from you. Reply to this email with your questions, comments, or general feedback, and I'll get back to you as soon as I can. Wishing you big returns on your investments this week, as always! - Michael "The Stock Dork" Taylor Disclaimer© 2023 TheStockDork.com. All rights reserved. This message was sent by TheStockDork.com and may contain commercial elements such as advertising. Read full terms here. |
|
|
|
| | |
|
